JAK3 and rheumatoid arthritis: The results of the present study show that high baseline JAK3 phosphorylation in all peripheral blood leukocyte subtypes studied (i.e., CD4+ and CD8+ T cells, B cells, and monocytes) is associated with remission achieved by sDMARDs among patients with early untreated RA.